Evidence map›Paper›PMID 39217271›Full record

Trial reportNature medicine2024

Digital consults in heart failure care: a randomized controlled trial.

Jelle P Man, Maarten A C Koole, Paola G Meregalli, M Louis Handoko, Susan Stienen, Frederik J de Lange, Michiel M Winter, Marlies P Schijven, Wouter E M Kok, Dorianne I Kuipers and 6 more

Erratum issued 3 registry-linked trialsAbstract readRandomized Controlled TrialMulticenter Study
In one paragraph

Trial report in Nature medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to 3 registered trials, which are not on this map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05413447 nacompletednot on this map

Assessment of Digital Consultations on Clinical Impact and Efficiency Using a RCT (ADMINISTER) Trial

TypeinterventionalSponsorAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)Ran2022 to 2024Enrolled150ConditionsHeart FailureArmsDigital consult
NCT06844006 naenrolling by invitationnot on this map

Assessment of Digital Care on Clinical Impact and Efficiency Using a Stepped Wedge Cluster RCT in Heart Failure Patients: the ADMINISTER II Trial

TypeinterventionalSponsorMedisch Spectrum TwenteRan2024 to 2028Enrolled1,320ConditionsHeart FailureArmsNudging
NCT07518030 narecruitingnot on this mapstarted 2026, after this paper: background citation

TELEHEART Trial: Telemedicine-guided Uptitration of Therapy in Chronic Heart Failure

TypeinterventionalSponsorAzienda Unita Sanitaria Locale di PiacenzaRan2026 to 2028Enrolled80ConditionsHeart Failure With Reduced Ejection Fraction (HFrEF)ArmsTelemedicine-based follow-up, Standard follow-up
3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Trial
  2. Article
  3. Review
  4. Review
  5. Observational
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors.

Jelle P ManDepartment of Cardiology, Amsterdam UMC, Amsterdam, The Netherlands.ORCID http://orcid.org/0000-0003-2040-3686
Maarten A C KooleDepartment of Cardiology, Amsterdam UMC, Amsterdam, The Netherlands.ORCID http://orcid.org/0000-0002-0437-7329
Paola G MeregalliDepartment of Cardiology, Amsterdam UMC, Amsterdam, The Netherlands.
M Louis HandokoDepartment of Cardiology, Amsterdam UMC, Amsterdam, The Netherlands.ORCID http://orcid.org/0000-0002-8942-7865
Susan StienenDepartment of Cardiology, Amsterdam UMC, Amsterdam, The Netherlands.ORCID http://orcid.org/0000-0002-5573-9377
Frederik J de LangeDepartment of Cardiology, Amsterdam UMC, Amsterdam, The Netherlands.ORCID http://orcid.org/0000-0002-7590-9230
Michiel M WinterDepartment of Cardiology, Amsterdam UMC, Amsterdam, The Netherlands.
Marlies P SchijvenDepartment of Surgery, Amsterdam UMC, Amsterdam, The Netherlands.ORCID http://orcid.org/0000-0001-7013-0116
Wouter E M KokDepartment of Cardiology, Amsterdam UMC, Amsterdam, The Netherlands.ORCID http://orcid.org/0000-0002-7789-6285
Dorianne I KuipersDepartment of Cardiology, Amsterdam UMC, Amsterdam, The Netherlands.
Pim van der HarstDepartment of Cardiology, University Medical Center Utrecht, Utrecht, The Netherlands.ORCID http://orcid.org/0000-0002-2713-686X
Folkert W AsselbergsDepartment of Cardiology, Amsterdam UMC, Amsterdam, The Netherlands.ORCID http://orcid.org/0000-0002-1692-8669
Aeilko H ZwindermanDepartment of Epidemiology and Data Science, Amsterdam UMC, Amsterdam, The Netherlands.ORCID http://orcid.org/0000-0003-0361-3139
Marcel G W DijkgraafDepartment of Epidemiology and Data Science, Amsterdam UMC, Amsterdam, The Netherlands.ORCID http://orcid.org/0000-0003-0750-8790
Steven A J ChamuleauDepartment of Cardiology, Amsterdam UMC, Amsterdam, The Netherlands.ORCID http://orcid.org/0000-0002-9952-6701
Mark J SchuuringDepartment of Cardiology, Medical Spectrum Twente, Enschede, The Netherlands. mark.schuuring@utwente.nl.ORCID http://orcid.org/0000-0002-2843-1852

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Guideline-directed medical therapy (GDMT) has clear benefits on morbidity and mortality in patients with heart failure; however, GDMT use remains low. In the multicenter, open-label, investigator-initiated ADMINISTER trial, patients (n = 150) diagnosed with heart failure and reduced ejection fraction (HFrEF) were randomized (1:1) to receive usual care or a strategy using digital consults (DCs). DCs contained (1) digital data sharing from patient to clinician (pharmacotherapy use, home-measured vital signs and Kansas City Cardiomyopathy Questionnaires); (2) patient education via a text-based e-learning; and (3) guideline recommendations to all treating clinicians. All remotely gathered information was processed into a digital summary that was available to clinicians in the electronic health record before every consult. All patient interactions were standardly conducted remotely. The primary endpoint was change in GDMT score over 12 weeks (ΔGDMT); this GDMT score directly incorporated all non-conditional class 1 indications for HFrEF therapy with equal weights. The ADMINISTER trial met its primary outcome of achieving a higher GDMT in the DC group after a follow-up of 12 weeks (ΔGDMT score in the DC group: median 1.19, interquartile range (0.25, 2.3) arbitrary units versus 0.08 (0.00, 1.00) in usual care; P < 0.001). To our knowledge, this is the first multicenter randomized controlled trial that proves a DC strategy is effective to achieve GDMT optimization. ClinicalTrials.gov registration: NCT05413447 .

Indexed as

Heart FailureAgedFemaleHumansMaleMiddle AgedReferral and ConsultationStroke Volume

Identifiers

PMID39217271
PMCPMC11485254

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.